136 related articles for article (PubMed ID: 2142483)
1. Etretin. A replacement for etretinate.
O'Brien TJ
Int J Dermatol; 1990 May; 29(4):270-1. PubMed ID: 2142483
[No Abstract] [Full Text] [Related]
2. Acitretin versus etretinate in severe psoriasis. A double-blind randomized Nordic multicenter study in 168 patients.
Bjerke JR; Geiger JM
Acta Derm Venereol Suppl (Stockh); 1989; 146():206-7. PubMed ID: 2532847
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of etretin and etretinate during long-term treatment of psoriasis patients.
Larsen FG; Jakobsen P; Larsen CG; Kragballe K; Nielsen-Kudsk F
Pharmacol Toxicol; 1988 Mar; 62(3):159-65. PubMed ID: 2967472
[TBL] [Abstract][Full Text] [Related]
4. Acitretin in the treatment of severe psoriasis: a randomized double-blind study comparing acitretin and etretinate.
Meffert H; Sönnichsen N
Acta Derm Venereol Suppl (Stockh); 1989; 146():176-7. PubMed ID: 2532846
[No Abstract] [Full Text] [Related]
5. Acitretin versus etretinate in psoriasis. Clinical and pharmacokinetic results of a German multicenter study.
Gollnick H; Bauer R; Brindley C; Orfanos CE; Plewig G; Wokalek H; Hoting E
J Am Acad Dermatol; 1988 Sep; 19(3):458-68. PubMed ID: 2971692
[TBL] [Abstract][Full Text] [Related]
6. Acitretin (Ro 10-1670, etretin): overall evaluation of clinical studies.
Geiger JM; Czarnetzki BM
Dermatologica; 1988; 176(4):182-90. PubMed ID: 2967779
[TBL] [Abstract][Full Text] [Related]
7. Etretin therapy for severe psoriasis. Evaluation of initial clinical responses.
Kingston TP; Matt LH; Lowe NJ
Arch Dermatol; 1987 Jan; 123(1):55-8. PubMed ID: 2948451
[TBL] [Abstract][Full Text] [Related]
8. Etretinate pharmacokinetics in chronic renal failure. A preliminary study in psoriasis patients.
Vahlquist A
Dermatologica; 1987; 175(5):224-8. PubMed ID: 2960573
[TBL] [Abstract][Full Text] [Related]
9. Acitretin (Ro 10-1670) in the treatment of severe psoriasis. A randomized double-blind parallel study comparing acitretin and etretinate.
Ledo A; Martín M; Geiger JM; Marrón JM
Int J Dermatol; 1988 Nov; 27(9):656-60. PubMed ID: 2976406
[TBL] [Abstract][Full Text] [Related]
10. A double-blind comparison of acitretin and etretinate in the treatment of severe psoriasis. Results of a Nordic multicentre study.
Kragballe K; Jansén CT; Geiger JM; Bjerke JR; Falk ES; Gip L; Hjorth N; Lauharanta J; Mork NJ; Reunala T
Acta Derm Venereol; 1989; 69(1):35-40. PubMed ID: 2563606
[TBL] [Abstract][Full Text] [Related]
11. Randomized double-blind multicenter study comparing acitretin-PUVA, etretinate-PUVA and placebo-PUVA in the treatment of severe psoriasis.
Saurat JH; Geiger JM; Amblard P; Beani JC; Boulanger A; Claudy A; Frenk E; Guilhou JJ; Grosshans E; Mérot Y
Dermatologica; 1988; 177(4):218-24. PubMed ID: 2976000
[TBL] [Abstract][Full Text] [Related]
12. A double-blind comparison of acitretin and etretinate in combination with bath PUVA in the treatment of extensive psoriasis.
Lauharanta J; Geiger JM
Br J Dermatol; 1989 Jul; 121(1):107-12. PubMed ID: 2527054
[TBL] [Abstract][Full Text] [Related]
13. Retinoids: an overview of pharmacokinetics and therapeutic value.
Gollnick H; Ehlert R; Rinck G; Orfanos CE
Methods Enzymol; 1990; 190():291-304. PubMed ID: 2150872
[No Abstract] [Full Text] [Related]
14. Acitretin and etretinate in the treatment of palmoplantar pustulosis: a double-blind comparative trial.
Lassus A; Geiger JM
Br J Dermatol; 1988 Dec; 119(6):755-9. PubMed ID: 2974306
[TBL] [Abstract][Full Text] [Related]
15. Systemic retinoid therapy for psoriasis.
Lowe NJ; Lazarus V; Matt L
J Am Acad Dermatol; 1988 Jul; 19(1 Pt 2):186-91. PubMed ID: 2970476
[TBL] [Abstract][Full Text] [Related]
16. Transplacental pharmacokinetics of teratogenic doses of etretinate and other aromatic retinoids in mice.
Reiners J; Löfberg B; Kraft JC; Kochhar DM; Nau H
Reprod Toxicol; 1988; 2(1):19-29. PubMed ID: 2980988
[TBL] [Abstract][Full Text] [Related]
17. Acitretin. A review of its pharmacology and therapeutic use.
Pilkington T; Brogden RN
Drugs; 1992 Apr; 43(4):597-627. PubMed ID: 1377120
[TBL] [Abstract][Full Text] [Related]
18. Single dose pharmacokinetics of etretin and etretinate in psoriatic patients.
Larsen FG; Jakobsen P; Larsen CG; Nørgaard A; Kragballe K; Nielsen-Kudsk F
Pharmacol Toxicol; 1987 Aug; 61(2):85-8. PubMed ID: 2959917
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacokinetics of etretinate, acitretin and 13-cis-acitretin: new results and advantages of blood level oriented clinical use].
Gollnick H; Rinck G; Bitterling T; Orfanos CE
Z Hautkr; 1990 Jan; 65(1):40-50. PubMed ID: 2139274
[TBL] [Abstract][Full Text] [Related]
20. Treatment of psoriasis with etretin: a preliminary report.
Madhok R; Muller SA; Dicken CH
Mayo Clin Proc; 1987 Dec; 62(12):1084-9. PubMed ID: 2960861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
